Jorge C. Paradelo

3.4k total citations · 2 hit papers
21 papers, 2.4k citations indexed

About

Jorge C. Paradelo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jorge C. Paradelo has authored 21 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jorge C. Paradelo's work include Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers) and Advanced Radiotherapy Techniques (4 papers). Jorge C. Paradelo is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (6 papers) and Advanced Radiotherapy Techniques (4 papers). Jorge C. Paradelo collaborates with scholars based in United States, Canada and Tanzania. Jorge C. Paradelo's co-authors include Ian M. Thompson, E. David Crawford, Gary J. Miller, Catherine M. Tangen, M. Scott Lucia, Gregory P. Swanson, Joseph L. Chin, Dean A. Troyer, Edward M. Messing and Jeffrey D. Forman and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Jorge C. Paradelo

21 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

2009 826 citations Ian M. Thompson, Catherine M. Tangen et al. The Journal of Urology profile →
Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer

2006 664 citations Ian M. Thompson, Catherine M. Tangen et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge C. Paradelo United States	12	1.9k	710	523	493	361	21	2.4k
J Mesić United States	9	1.5k 0.8×	298 0.4×	404 0.8×	432 0.9×	177 0.5×	13	1.9k
Madhu J. John United States	25	1.7k 0.9×	338 0.5×	375 0.7×	1.1k 2.3×	153 0.4×	44	2.4k
Ferrán Guedea Spain	20	1.0k 0.5×	411 0.6×	699 1.3×	416 0.8×	205 0.6×	102	2.1k
R. L. Scotte Doggett United States	20	864 0.5×	297 0.4×	239 0.5×	440 0.9×	101 0.3×	26	1.3k
Paul C.M.S. Verhagen Netherlands	19	1.6k 0.8×	196 0.3×	223 0.4×	239 0.5×	191 0.5×	49	1.9k
Andrew A. Renshaw United States	14	1.2k 0.6×	191 0.3×	102 0.2×	287 0.6×	210 0.6×	21	1.5k
O. Kenneth Macdonald United States	23	710 0.4×	367 0.5×	330 0.6×	442 0.9×	146 0.4×	40	1.6k
Anas M. El‐Mahdi United States	22	876 0.5×	215 0.3×	214 0.4×	403 0.8×	192 0.5×	69	1.3k
Myla Strawderman United States	13	1.3k 0.7×	392 0.6×	182 0.3×	1.4k 2.8×	24 0.1×	26	2.3k
Antoine Lusinchi France	23	859 0.5×	745 1.0×	219 0.4×	1.2k 2.5×	68 0.2×	34	2.2k

Countries citing papers authored by Jorge C. Paradelo

Since Specialization

Citations

This map shows the geographic impact of Jorge C. Paradelo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge C. Paradelo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge C. Paradelo more than expected).

Fields of papers citing papers by Jorge C. Paradelo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge C. Paradelo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge C. Paradelo. The network helps show where Jorge C. Paradelo may publish in the future.

Co-authorship network of co-authors of Jorge C. Paradelo

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge C. Paradelo. A scholar is included among the top collaborators of Jorge C. Paradelo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge C. Paradelo. Jorge C. Paradelo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, Ian M., Catherine M. Tangen, Jorge C. Paradelo, et al.. (2009). Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial. The Journal of Urology. 181(3). 956–962. 826 indexed citations breakdown →

Thompson, Ian M., Catherine M. Tangen, Jorge C. Paradelo, et al.. (2006). Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer. JAMA. 296(19). 2329–2329. 664 indexed citations breakdown →

Williamson, Stephen K., Sheryl McCoy, David R. Gandara, et al.. (2006). Phase II Trial of Gemcitabine Plus Irinotecan In Patients With Esophageal Cancer. American Journal of Clinical Oncology. 29(2). 116–122. 8 indexed citations

Thompson, Ian M., Catherine M. Tangen, Gary J. Miller, et al.. (2005). 1665: Adjuvant Radiotherapy for Pathologic T3 Prostate Cancer: Results of a Randomized, Prospective Clinical Trial with Metastasis-Free Survival Endpoint. The Journal of Urology. 173(4S). 451–452. 11 indexed citations

Swanson, Gregory P., Ian M. Thompson, Catherine M. Tangen, et al.. (2005). Phase III Randomized Study of Adjuvant Radiation Therapy versus Observation in Patients with Pathologic T3 Prostate Cancer (SWOG 8794). International Journal of Radiation Oncology*Biology*Physics. 63. S1–S1. 34 indexed citations

Rich, Tyvin A., Jonathan Harris, Ross A. Abrams, et al.. (2004). Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12. American Journal of Clinical Oncology. 27(1). 51–56. 72 indexed citations

Urba, Susan G., Sarah A. Taylor, Jorge C. Paradelo, J. L. Abbruzzese, & Kari Chansky. (2001). Gemcitabine and cisplatin chemotherapy for patients with metastatic esophageal carcinoma. European Journal of Cancer. 37. S287–S287. 1 indexed citations

Rich, Tyvin A., Jonathan Harris, R. A. Abrams, et al.. (2001). A phase II study of external irradiation and weekly paclitaxel for non-metastatic, unresectable pancreatic cancer: a preliminary report of RTOG Protocol 98-12. International Journal of Radiation Oncology*Biology*Physics. 51(3). 29–30. 11 indexed citations

Ellis, Georgiana K., Stephanie Green, Robert B. Livingston, et al.. (1999). ‘Neo-FAC’ (5-Fluorouracil, Doxorubicin, and Cyclophosphamide) for Poor-Prognosis Stage IV Breast Cancer. American Journal of Clinical Oncology. 22(5). 446–446. 1 indexed citations

10.

Taylor, Charles W., William S. Dalton, Silvana Martino, et al.. (1998). Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.. Journal of Clinical Oncology. 16(3). 994–999. 142 indexed citations

11.

Gordon, William, Kimberly D. Siegmund, Thomas H. Stanisic, et al.. (1997). A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). International Journal of Radiation Oncology*Biology*Physics. 38(1). 83–94. 45 indexed citations

12.

Smith, Joseph A., E. David Crawford, Jorge C. Paradelo, et al.. (1997). Treatment of Advanced Bladder Cancer With Combined Preoperative Irradiation and Radical Cystectomy Versus Radical Cystectomy Alone: A Phase III Intergroup Study. The Journal of Urology. 157(3). 805–808. 48 indexed citations

13.

Thompson, Ian M., et al.. (1994). An opportunity to determine optimaltreatment of pT3 prostate cancer: The window may be closing. Urology. 44(6). 804–811. 12 indexed citations

14.

Paradelo, Jorge C., et al.. (1992). Endobronchial Irradiation with 192Ir in the Treatment of Malignant Endobronchial Obstruction. CHEST Journal. 102(4). 1072–1074. 9 indexed citations

15.

Paradelo, Jorge C., et al.. (1991). Conservative therapy for anal carcinoma: An analysis of prognostic factors. International Journal of Radiation Oncology*Biology*Physics. 21. 224–224. 16 indexed citations

16.

Russell, Anthony H., H. Selim, Jorge C. Paradelo, et al.. (1991). Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the radiation therapy oncology group. International Journal of Radiation Oncology*Biology*Physics. 21(3). 637–643. 122 indexed citations

17.

Griffin, John F., Stephen R. Smalley, William R. Jewell, et al.. (1990). Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 66(1). 56–61. 341 indexed citations

18.

Russell, Anthony H., H. Selim, Jorge C. Paradelo, et al.. (1990). Prophylactic cranial irradiation (PCI) for selected lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial. International Journal of Radiation Oncology*Biology*Physics. 19. 146–146. 2 indexed citations

19.

Paradelo, Jorge C., et al.. (1984). Curative radiotherapy and COPD: Prediction of lung tolerance. International Journal of Radiation Oncology*Biology*Physics. 10. 187–187. 1 indexed citations

20.

Paradelo, Jorge C., et al.. (1981). Mid-sagittal plane dosimetry in patients with extensive head and neck malignancy. International Journal of Radiation Oncology*Biology*Physics. 7(1). 115–120. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact